Dr. Shawn Lee, MD

Dr. Lee practices at Saint Barnabas Rcg Dialysis Center-Livingston - HOPD in Livingston, New Jersey.

Dr. Lee's NPI, 1942695374, was assigned on April 2, 2015. Dr. Lee holds New Jersey license 25MA12128500.

Dr. Lee's primary practice is Saint Barnabas Rcg Dialysis Center-Livingston - HOPD, at 200 S Orange Ave, Livingston, NJ 07039.

Dr. Lee's primary practice is Saint Barnabas Rcg Dialysis Center-Livingston - HOPD in Livingston, New Jersey. Dr. Lee is also affiliated with Mount Sinai West. The medical group on file is RWJBarnabas Health Medical Group. Dmand AI also links Dr. Lee to 4 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lee practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Lee's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Lee's licenses on file in 2 states: New Jersey and New York.

CMS data shows 632 Medicare services from Dr. Lee across 20 procedure codes in 2024, for 261 Medicare patients. Medicare paid $52,667 for them.

CMS counts 261 Medicare patients who saw Dr. Lee in 2024. The largest group is 75 to 84, with 115 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lee's median patient age at 79, with 48% women.

In 2024, Dr. Lee wrote 196 Medicare Part D claims for 93 patients. 84% of them were for generic drugs. CMS names the drug for 121 of them, across 5 drugs with 11 or more claims each, at $22,290 in total drug cost. In 2023, CMS named 320 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Lee for performance year 2024, reported through an alternative payment model (APM). Dr. Lee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 67 procedures of pacemaker insertion or repair by Dr. Lee, more than 94% of the clinicians it reports for that procedure.

CMS Open Payments shows 151 general payments to Dr. Lee from 24 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 59% of the total. Medtronic, Inc. paid the most, $3,793.